Need help finding what you are looking for?
Contact Us
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1269445
PUBLISHER: Transparency Market Research | PRODUCT CODE: 1269445
Vasopressin Antagonists Market (Application: Central Diabetes Insipidus, Nephrogenic Diabetes Insipidus, and Other Applications) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031
PUBLISHED:
PAGES: 183 Pages
DELIVERY TIME: 2-10 business days
SELECT AN OPTION
Vasopressin Antagonists Market - Scope of Report:
TMR's report on the global vasopressin antagonists market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global vasopressin antagonists market for the period 2017-2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global vasopressin antagonists market from 2023 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the vasopressin antagonists market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global vasopressin antagonists market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global vasopressin antagonists market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global vasopressin antagonists market.
The report delves into the competitive landscape of the global vasopressin antagonists market. Key players operating in the global vasopressin antagonists market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global vasopressin antagonists market profiled in this report.
Key Questions Answered in Global Vasopressin Antagonists Market Report:
- What is the sales/revenue generated by vasopressin antagonists across all regions during the forecast period?
- What are the opportunities in the global vasopressin antagonists market?
- What are the major drivers, restraints, opportunities, and threats in the market?
- Which regional market is set to expand at the fastest CAGR during the forecast period?
- Which segment is expected to generate the highest revenue globally in 2031?
- Which segment is projected to expand at the highest CAGR during the forecast period?
- What are the market positions of different companies operating in the global market?
Vasopressin Antagonists Market - Research Objectives and Research Approach:
The comprehensive report on the global vasopressin antagonists market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global vasopressin antagonists market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global vasopressin antagonists market.
Product Code: TMRGL85509
Table of Contents
1. Preface
- 1.1. Market Definition and Scope
- 1.2. Market Segmentation
- 1.3. Key Research Objectives
- 1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Vasopressin Antagonists Market
4. Market Overview
- 4.1. Introduction
- 4.1.1. Drug Type Definition
- 4.1.2. Industry Evolution / Developments
- 4.2. Overview
- 4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
- 4.4. Global Vasopressin Antagonists Market Analysis and Forecast, 2017-2031
5. Key Insights
- 5.1. Pipeline Analysis
- 5.2. Disease Incidence and Prevalence
- 5.3. Regulatory Approval
- 5.4. COVID-19 Impact Analysis
6. Global Vasopressin Antagonists Market Analysis and Forecast, by Drug Type
- 6.1. Introduction & Definition
- 6.2. Key Findings / Developments
- 6.3. Market Value Forecast, by Drug Type, 2017-2031
- 6.3.1. Vaprisol
- 6.3.2. Tolvaptan
- 6.4. Market Attractiveness Analysis, by Drug Type
7. Global Vasopressin Antagonists Market Analysis and Forecast, by Application
- 7.1. Introduction & Definition
- 7.2. Key Findings / Developments
- 7.3. Market Value Forecast, by Application, 2017-2031
- 7.3.1. Central Diabetes Insipidus
- 7.3.2. Nephrogenic Diabetes Insipidus
- 7.3.3. Other Applications
- 7.4. Market Attractiveness Analysis, by Application
8. Global Vasopressin Antagonists Market Analysis and Forecast, by Distribution Channel
- 8.1. Introduction & Definition
- 8.2. Key Findings / Developments
- 8.3. Market Value Forecast, by Distribution Channel, 2017-2031
- 8.3.1. Retail Pharmacies
- 8.3.2. Hospital Pharmacies
- 8.3.3. Online Pharmacies
- 8.4. Market Attractiveness Analysis, by Distribution Channel
9. Global Vasopressin Antagonists Market Analysis and Forecast, by Region
- 9.1. Key Findings
- 9.2. Market Value Forecast, by Region
- 9.2.1. North America
- 9.2.2. Europe
- 9.2.3. Asia Pacific
- 9.2.4. Latin America
- 9.2.5. Middle East & Africa
- 9.3. Market Attractiveness Analysis, by Region
10. North America Vasopressin Antagonists Market Analysis and Forecast
- 10.1. Introduction
- 10.1.1. Key Findings
- 10.2. Market Value Forecast, by Drug Type, 2017-2031
- 10.2.1. Vaprisol
- 10.2.2. Tolvaptan
- 10.3. Market Value Forecast, by Application, 2017-2031
- 10.3.1. Central Diabetes Insipidus
- 10.3.2. Nephrogenic Diabetes Insipidus
- 10.3.3. Other Applications
- 10.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 10.4.1. Retail Pharmacies
- 10.4.2. Hospital Pharmacies
- 10.4.3. Online Pharmacies
- 10.5. Market Value Forecast, by Country, 2017-2031
- 10.5.1. U.S.
- 10.5.2. Canada
- 10.6. Market Attractiveness Analysis
- 10.6.1. By Drug Type
- 10.6.2. By Application
- 10.6.3. By Distribution Channel
- 10.6.4. By Country
11. Europe Vasopressin Antagonists Market Analysis and Forecast
- 11.1. Introduction
- 11.1.1. Key Findings
- 11.2. Market Value Forecast, by Drug Type, 2017-2031
- 11.2.1. Vaprisol
- 11.2.2. Tolvaptan
- 11.3. Market Value Forecast, by Application, 2017-2031
- 11.3.1. Central Diabetes Insipidus
- 11.3.2. Nephrogenic Diabetes Insipidus
- 11.3.3. Other Applications
- 11.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 11.4.1. Retail Pharmacies
- 11.4.2. Hospital Pharmacies
- 11.4.3. Online Pharmacies
- 11.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 11.5.1. Germany
- 11.5.2. U.K.
- 11.5.3. France
- 11.5.4. Spain
- 11.5.5. Italy
- 11.5.6. Rest of Europe
- 11.6. Market Attractiveness Analysis
- 11.6.1. By Drug Type
- 11.6.2. By Application
- 11.6.3. By Distribution Channel
- 11.6.4. By Country/Sub-region
12. Asia Pacific Vasopressin Antagonists Market Analysis and Forecast
- 12.1. Introduction
- 12.1.1. Key Findings
- 12.2. Market Value Forecast, by Drug Type, 2017-2031
- 12.2.1. Vaprisol
- 12.2.2. Tolvaptan
- 12.3. Market Value Forecast, by Application, 2017-2031
- 12.3.1. Central Diabetes Insipidus
- 12.3.2. Nephrogenic Diabetes Insipidus
- 12.3.3. Other Applications
- 12.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 12.4.1. Retail Pharmacies
- 12.4.2. Hospital Pharmacies
- 12.4.3. Online Pharmacies
- 12.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 12.5.1. China
- 12.5.2. Japan
- 12.5.3. India
- 12.5.4. Australia & New Zealand
- 12.5.5. Rest of Asia Pacific
- 12.6. Market Attractiveness Analysis
- 12.6.1. By Drug Type
- 12.6.2. By Application
- 12.6.3. By Distribution Channel
- 12.6.4. By Country/Sub-region
13. Latin America Vasopressin Antagonists Market Analysis and Forecast
- 13.1. Introduction
- 13.1.1. Key Findings
- 13.2. Market Value Forecast, by Drug Type, 2017-2031
- 13.2.1. Vaprisol
- 13.2.2. Tolvaptan
- 13.3. Market Value Forecast, by Application, 2017-2031
- 13.3.1. Central Diabetes Insipidus
- 13.3.2. Nephrogenic Diabetes Insipidus
- 13.3.3. Other Applications
- 13.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 13.4.1. Retail Pharmacies
- 13.4.2. Hospital Pharmacies
- 13.4.3. Online Pharmacies
- 13.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 13.5.1. Brazil
- 13.5.2. Mexico
- 13.5.3. Rest of Latin America
- 13.6. Market Attractiveness Analysis
- 13.6.1. By Drug Type
- 13.6.2. By Application
- 13.6.3. By Distribution Channel
- 13.6.4. By Country/Sub-region
14. Middle East & Africa Vasopressin Antagonists Market Analysis and Forecast
- 14.1. Introduction
- 14.1.1. Key Findings
- 14.2. Market Value Forecast, by Drug Type, 2017-2031
- 14.2.1. Vaprisol
- 14.2.2. Tolvaptan
- 14.3. Market Value Forecast, by Application, 2017-2031
- 14.3.1. Central Diabetes Insipidus
- 14.3.2. Nephrogenic Diabetes Insipidus
- 14.3.3. Other Applications
- 14.4. Market Value Forecast, by Distribution Channel, 2017-2031
- 14.4.1. Retail Pharmacies
- 14.4.2. Hospital Pharmacies
- 14.4.3. Online Pharmacies
- 14.5. Market Value Forecast, by Country/Sub-region, 2017-2031
- 14.5.1. GCC Countries
- 14.5.2. South Africa
- 14.5.3. Rest of Middle East & Africa
- 14.6. Market Attractiveness Analysis
- 14.6.1. By Drug Type
- 14.6.2. By Application
- 14.6.3. By Distribution Channel
- 14.6.4. By Country/Sub-region
15. Competition Landscape
- 15.1. Market Player - Competition Matrix (by tier and size of companies)
- 15.2. Market Share Analysis, by Company, 2022
- 15.3. Company Profiles
- 15.3.1. Otsuka
- 15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.1.2. Test Drug Type Portfolio
- 15.3.1.3. Financial Overview
- 15.3.1.4. SWOT Analysis
- 15.3.1.5. Strategic Overview
- 15.3.2. Cumberland Pharmaceuticals
- 15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.2.2. Test Drug Type Portfolio
- 15.3.2.3. Financial Overview
- 15.3.2.4. SWOT Analysis
- 15.3.2.5. Strategic Overview
- 15.3.3. Mayo Clinic
- 15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.3.2. Test Drug Type Portfolio
- 15.3.3.3. Financial Overview
- 15.3.3.4. SWOT Analysis
- 15.3.3.5. Strategic Overview
- 15.3.4. Hopital du Sacre-Coeur de Montreal
- 15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
- 15.3.4.2. Test Drug Type Portfolio
- 15.3.4.3. Financial Overview
- 15.3.4.4. SWOT Analysis
- 15.3.4.5. Strategic Overview
- 15.3.1. Otsuka
Product Code: TMRGL85509
List of Tables
- Table 1: Global overview of Vasopressin Antagonists
- Table 2: Regional overview of Vasopressin Antagonists
- Table 3: North America Overview of Vasopressin Antagonists
- Table 4: APAC overview of Vasopressin Antagonists
- Table 5: Global Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
- Table 6: Global Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 7: Global Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
- Table 8: Global Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Region, 2017-2031
- Table 9: North America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Country, 2017-2031
- Table 10: North America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
- Table 11: North America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 12: North America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
- Table 13: Europe Vasopressin Antagonists Market Revenue (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 14: Europe Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
- Table 15: Europe Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 16: Europe Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
- Table 17: Asia Pacific Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 18: Asia Pacific Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
- Table 19: Asia Pacific Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 20: Asia Pacific Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
- Table 21: Latin America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 22: Latin America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
- Table 23: Latin America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 24: Latin America Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
- Table 25: Middle East & Africa Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
- Table 26: Middle East & Africa Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Drug Type, 2017-2031
- Table 27: Middle East & Africa Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Application, 2017-2031
- Table 28: Middle East & Africa Vasopressin Antagonists Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
List of Figures
- Figure 01: Global Vasopressin Antagonists Market Value (US$ Mn) Forecast, 2017-2031
- Figure 02: Global Vasopressin Antagonists Market Size (US$ Mn) Forecast, 2017-2031
- Figure 03: Global Vasopressin Antagonists Market Value Share, by Drug Type (2022)
- Figure 04: Global Vasopressin Antagonists Market Value Share, by Application (2022)
- Figure 05: Global Vasopressin Antagonists Market Value Share, by Distribution Channel (2022)
- Figure 06: Global Vasopressin Antagonists Market Value Share, by Region (2022)
- Figure 07: Global Vasopressin Antagonists Market Value Share, by Drug Type, 2022 and 2031
- Figure 08 Global Vasopressin Antagonists Market Attractiveness Analysis, by Drug Type, 2023-2031
- Figure 09: Global Vasopressin Antagonists Market Value Share, by Application, 2022 and 2031
- Figure 10: Global Vasopressin Antagonists Market Attractiveness Analysis, by Application, 2023-2031
- Figure 11: Global Vasopressin Antagonists Market Value Share, by Distribution Channel, 2022 and 2031
- Figure 12: Global Vasopressin Antagonists Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 13: Global Vasopressin Antagonists Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
- Figure 14: Global Vasopressin Antagonists Market Value Share, by Region, 2023-2031
- Figure 15: Global Vasopressin Antagonists Market Attractiveness Analysis, by Region, 2023-2031
- Figure 16: North America Vasopressin Antagonists Market Value Share, by Drug Type, 2022 and 2031
- Figure 17: North America Vasopressin Antagonists Market Attractiveness Analysis, by Drug Type, 2023-2031
- Figure 18: North America Vasopressin Antagonists Market Value Share, by Application, 2022 and 2031
- Figure 19: North America Vasopressin Antagonists Market Attractiveness Analysis, by Application, 2023-2031
- Figure 20: North America Vasopressin Antagonists Market Value Share, by Distribution Channel, 2022 and 2031
- Figure 21: North America Vasopressin Antagonists Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 22: North America Vasopressin Antagonists Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
- Figure 23: North America Vasopressin Antagonists Market Value Share, by Country, 2023-2031
- Figure 24: North America Vasopressin Antagonists Market Attractiveness Analysis, by Country, 2023-2031
- Figure 25: Europe Vasopressin Antagonists Market Value Share, by Drug Type, 2022 and 2031
- Figure 26: Europe Vasopressin Antagonists Market Attractiveness Analysis, by Drug Type, 2023-2031
- Figure 27: Europe Vasopressin Antagonists Market Value Share, by Application, 2022 and 2031
- Figure 28: Europe Vasopressin Antagonists Market Attractiveness Analysis, by Application, 2023-2031
- Figure 29: Europe Vasopressin Antagonists Market Value Share, by Distribution Channel, 2022 and 2031
- Figure 30: Europe Vasopressin Antagonists Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 31: Europe Vasopressin Antagonists Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
- Figure 32: Europe Vasopressin Antagonists Market Value Share, by Country/Sub-region, 2022-2031
- Figure 33: Europe Vasopressin Antagonists Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 34: Asia Pacific Vasopressin Antagonists Market Value Share, by Drug Type, 2022 and 2031
- Figure 35: Asia Pacific Vasopressin Antagonists Market Attractiveness Analysis, by Drug Type, 2023-2031
- Figure 36: Asia Pacific Vasopressin Antagonists Market Value Share, by Application, 2022 and 2031
- Figure 37: Asia Pacific Vasopressin Antagonists Market Attractiveness Analysis, by Application, 2023-2031
- Figure 38: Asia Pacific Vasopressin Antagonists Market Value Share, by Distribution Channel, 2022 and 2031
- Figure 39: Asia Pacific Vasopressin Antagonists Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 40: Asia Pacific Vasopressin Antagonists Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
- Figure 41: Asia Pacific Vasopressin Antagonists Market Value Share, by Country/Sub-region, 2022-2031
- Figure 42: Asia Pacific Vasopressin Antagonists Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 43: Latin America Vasopressin Antagonists Market Value Share, by Drug Type, 2022 and 2031
- Figure 44: Latin America Vasopressin Antagonists Market Attractiveness Analysis, by Drug Type, 2023-2031
- Figure 45: Latin America Vasopressin Antagonists Market Value Share, by Application, 2022 and 2031
- Figure 46: Latin America Vasopressin Antagonists Market Attractiveness Analysis, by Application, 2023-2031
- Figure 47: Latin America Vasopressin Antagonists Market Value Share, by Distribution Channel, 2022 and 2031
- Figure 48: Latin America Vasopressin Antagonists Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 49: Latin America Vasopressin Antagonists Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
- Figure 50: Latin America Vasopressin Antagonists Market Value Share, by Country/Sub-region, 2022-2031
- Figure 51: Latin America Vasopressin Antagonists Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 52: Middle East & Africa Vasopressin Antagonists Market Value Share, by Drug Type, 2022 and 2031
- Figure 53: Middle East & Africa Vasopressin Antagonists Market Attractiveness Analysis, by Drug Type, 2023-2031
- Figure 54: Middle East & Africa Vasopressin Antagonists Market Value Share, by Application, 2022 and 2031
- Figure 55: Middle East & Africa Vasopressin Antagonists Market Attractiveness Analysis, by Application, 2023-2031
- Figure 56: Middle East & Africa Vasopressin Antagonists Market Value Share, by Distribution Channel, 2022 and 2031
- Figure 57: Middle East & Africa Vasopressin Antagonists Market Attractiveness Analysis, by Distribution Channel, 2023-2031
- Figure 58: Middle East & Africa Vasopressin Antagonists Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2017-2031
- Figure 59: Middle East & Africa Vasopressin Antagonists Market Value Share, by Country/Sub-region, 2022-2031
- Figure 60: Middle East & Africa Vasopressin Antagonists Market Attractiveness Analysis, by Country/Sub-region, 2023-2031
- Figure 61: Global Vasopressin Antagonists Market Share Analysis, by Company, 2022 (Estimated)
- Figure 62: Global Vasopressin Antagonists Market Performance, by Company, 2022
- Figure 63: Competition Matrix
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.